A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Over the years, researchers have learned more about when people should get the HPV vaccine. It was originally approved for females ages 9 through 26. Then the U.S. Food and Drug Administration (FDA) ...

Of the 9 studies which clearly reported participation rates, 7 had participation rates ranging from 79% to 100%. The remaining two studies had participation rates of 21.5% and 58% (Table 2).

Women in their 20s are the group most likely to have been given the HPV vaccine, which has been recommended in the U.S. since 2006 for girls at age 11 or 12 and since 2011 for boys the same age.

IT’S NOT TOO LATE. AND YOU KNOW, IN THIS STUDY IN SCOTLAND, ABOUT 9 IN 10 WOMEN HAD GOTTEN THE HPV VACCINE. HERE IN THE UNITED STATES, OUR RATES ARE LOWER. THERE ARE ABOUT 6 IN 10 PEOPLE HAVE ...

A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary Robert F. Kennedy Jr., is preventing cervical cancer in young women.